Abstract:Abstract Objectives: There is a lack of metrics that are representative of three-dimensional (3D) collagen fiber organization, despite the availability of high resolution 3D image stacks. This study aims to develop 3D orientation based biomarkers to quantify differences in the organization of collagen fibers between cancerous breast tissues and normal ones. Methods: We have developed a new method to characterize the 3D orientation of collagen fibers in high-resolution image stacks using a weighted vector sum approach that is computationally efficient and entirely automated in its implementation. In addition, it enables assessment of collagen fiber orientation both locally, i.e. within a specific region of the tissue volume imaged, and globally, i.e. within the entire 3D image stack. Using this approach, we compare the collagen fiber organization between normal mammary glands and mammary tumors. Normal mammary tissues are collected from the fourth mammary gland of non-parous 12 week old FVB/N female mice, while mammary tumors are obtained from mice with breast cancer. These tumors are composed of cancer cells of human origin that have stromalized with mouse ECM and cancer associated fibroblasts as well as immune cells, which are transplanted into the glands of NOD/SCID mice. We use 800 nm as the excitation wavelength, and acquire second harmonic generation (SHG) images at 400 ± 10 nm. A total of 6 SHG 3D image stacks per group (3 stacks per tissue sample) are collected for analysis. Results: The angular orientation distributions of the fibers indicate a “cross-hatched” organization in the normal tissues, while the formation of helical structures in the tumor specimens. This type of information is not possible to assess quantitatively if only 2D images are analyzed. In addition, we find that the collagen fibers of the tumor specimens exhibit significantly higher levels of alignment than the corresponding healthy mammary tissues. The presence of more highly aligned fibers within tumors is consistent with previous studies which assessed collagen organization using 2D images, even though 3D stacks were available. A possible reason for these changes in cancer may be associated with enhanced presence of newly synthesized collagen fibers. Significance: These findings are promising in terms of identifying collagen organization as a biomarker for the detection of cancer. We anticipate that quantitative assessment of three-dimensional organization will be a useful quantitative biomarker for a broad range of cancers as well as more fundamental investigations that aim to unravel the organization of essential fiber-like structures in tissues and ultimately its impact on tissue function. Citation Format: Zhiyi Liu, Lisa Arendt, Dimitra Pouli, Charlotte Kuperwasser, Irene Georgakoudi. Quantification of three-dimensional collagen fiber organization as a sensitive indicator of cancerous changes. [abstract]. In: Proceedings of the AACR Special Conference on Engineering and Physical Sciences in Oncology; 2016 Jun 25-28; Boston, MA. Philadelphia (PA): AACR; Cancer Res 2017;77(2 Suppl):Abstract nr B17.

Quantitative Measurement of Breast Carcinoma Fibrosis for the Prediction in the Risk of Bone Metastasis

Abstract B17: Quantification of Three-Dimensional Collagen Fiber Organization As a Sensitive Indicator of Cancerous Changes

Tumor angiogenesis and bone metastasis - Correlation in invasive breast carcinoma.

Automated quantification of aligned collagen for human breast carcinoma prognosis

Prognostic significance of collagen signatures at breast tumor boundary obtained by combining multiphoton imaging and imaging analysis

Study on Diagnostic Value of P1NP and Β-Ctx in Bone Metastasis of Patients with Breast Cancer and the Correlation Between Them.

The prognostic value of quantitative analysis of CCL5 and collagen IV in luminal B (HER2-) subtype breast cancer by quantum-dot-based molecular imaging.

The Value Analysis of Bone Metabolic Markers CTx, OST, BAP and PINP for Bone Metastases in Breast Cancer Patients

Application of Biomarkers for the Prediction and Diagnosis of Bone Metastasis in Breast Cancer

Analysis of clinicopathological factors associated with bone metastasis in breast cancer

Value of C-Telopeptide-Cross-Linked Type I Collagen, Osteocalcin, Bone-Specific Alkaline Phosphatase and Procollagen Type I N-Terminal Propeptide in the Diagnosis and Prognosis of Bone Metastasis in Patients with Malignant Tumors

Establishment of a Regression Model of Bone Metabolism Markers for the Diagnosis of Bone Metastases in Lung Cancer

Value of Serum Tumor Markers in Predicting Bone Metastases of Breast Cancer

Retrospective Evaluation of Bone Turnover Markers in Serum for the Prediction of Metastases Development in Breast Cancer Patients: A Cohort Study

Multi-factor Analysis on Prognosis in 100 Cases of Colorectal Cancer with Metastases

Prognostic Evaluation of Metastasis-Related Lymphocyte/Monocyte Ratio in Stage Ⅰ-Ⅲ Breast Cancer Receiving Chemotherapy

Clinical Features and Serological Markers Risk Model Predicts Overall Survival in Patients Undergoing Breast Cancer and Bone Metastasis Surgeries

Use of Elevated Bone Turnover to Predict Bone Metastasis

Clinical Association Between Pre-Treatment Levels of Plasma Fibrinogen and Bone Metastatic Burden in Newly Diagnosed Prostate Cancer Patients

Establishment and Validation of a Predictive Model for Bone Metastasis in Prostate Cancer Patients Based on Multiple Immune Inflammatory Parameters.

Values for Preoperative Staging of Fibrinogen,Inflammatory Mediators and Tumor Markers in Colorectal Cancer